Paul A. Romness - 31 Dec 2024 Form 5/A - Amendment Insider Report for OS Therapies Inc (OSTX)

Reporting relationship: President and CEO, Director
Issuer ticker: OSTX
Reported as of: 31 Dec 2024
Net transaction value: $0
SEC form: 5/A - Amendment
Accepted by SEC: 15 May 2026, 18:30:02 UTC
Original report date: 14 Feb 2025
Prior SEC filing: 01 Aug 2024
Next SEC filing: 28 Feb 2025
Source filing: View source filing
Reporting owner signature: /s/ Paul A. Romness

Key filing fact

Paul A. Romness filed Form 5/A - Amendment for OS Therapies Inc (OSTX) on 15 May 2026.

Key facts

This page summarizes Paul A. Romness's Form 5/A - Amendment filing for OS Therapies Inc (OSTX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 15 May 2026, 18:30.

Change

Previous filing in this sequence was filed on 01 Aug 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 5/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0001974517 Primary reporting owner

Romness Paul A.

Relationship: President and CEO, Director
Address: C/O OS THERAPIES INCORPORATED, 115 PULLMAN CROSSING ROAD, SUITE 103, GRASONVILLE
Signature: /s/ Paul A. Romness
Signature date: 15 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OSTX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 2,248,000
Date: 31 Dec 2024
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OSTX transaction Derivative

Non-qualified stock options (right to buy)

Award

Transaction value
Shares: +500,000
Change %
Price: $0.000000^*
Shares after: 500,000
Date: 05 Dec 2024
Ownership: Direct
Underlying class: Common stock, par value $0.001 per share
Underlying amount: 500,000
Exercise price: $1.86
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On December 5, 2024, the reporting person was granted non-qualified stock options to purchase 500,000 shares of the issuer's common stock pursuant to the terms and conditions of a stock option award agreement and subject to certain vesting conditions.

SEC remarks

On February 14, 2025, the reporting person filed a Form 5 that incorrectly reported the number of shares of common stock underlying the stock option award grant in Table II. This amended Form 5 is being filed solely to report in Table II the correct number of shares of common stock underlying the stock option award grant that occurred on December 5, 2024. This amended report does not report any new transactions or otherwise modify the transaction details that were previously reported.